Charles Evans, PhD, Vice-President of Pharmaceutical Development, has been with MedPharm for over 15 years and has been heavily involved in evolving and refining the company’s rigorous approach to formulation development. Dr Evans has many years of expertise in the successful development of robust commercial products across all types of topical, inhalation and transdermal formulations. Moreover, he played a key role in the development of MedPharm’s proprietary MedSpray® technology, which is currently under licence to customers to enhance their products’ performance.

Dr Evans obtained his PhD at the University of Hertfordshire (UK) for the development of a novel dynamic spray formulation for the treatment of athlete’s foot.